Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Real-Time Last Update
Volume
Day Low7.750
Day High7.990
Open:7.990
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDFRefinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDFStockCalc

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Download Premium PDFValueEngine

Latest News

More Stories
BioSyent Releases Financial Results for Q1 2022
Globe Newswire - Wed May 18, 7:00AM CDT
Globe Newswire
Wed May 18, 7:00AM CDT
MISSISSAUGA, Ontario, May 18, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three...
BioSyent Schedules Q1 2022 Earnings Release for May 18, 2022
Globe Newswire - Tue May 10, 3:30PM CDT
Globe Newswire
Tue May 10, 3:30PM CDT
MISSISSAUGA, Ontario, May 10, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results...
BioSyent to Present at 2022 Bloom Burton & Co. Healthcare Investor Conference
Globe Newswire - Tue Apr 26, 3:30PM CDT
Globe Newswire
Tue Apr 26, 3:30PM CDT
MISSISSAUGA, Ontario, April 26, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at...

Latest Articles

number cruncher
15 stocks beyond the index that offer growth at a reasonable price
Thursday’s analyst upgrades and downgrades: Rating changes for RBC, National Bank
Thursday’s analyst upgrades and downgrades
Market movers: Stocks that saw action on Monday - and why
Monday’s analyst upgrades and downgrades
Monday’s small-cap stocks to watch
me and my money
One active investor’s recipe for beating the market
Wednesday's analyst upgrades and downgrades
Monday's analyst upgrades and downgrades
Tuesday's analyst upgrades and downgrades
Wednesday's small-cap stocks to watch
bnn market call
Three top stock picks from Donville Kent’s Jason Donville

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2022.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2022 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.